Modified CRE recombinase gene for mammals
US6734295B1 · kind B1 · utility
1Cited by
0References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 14, 2000 |
| Grant date | May 11, 2004 |
| Priority date | — |
| Expiry date | Nov 17, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An object of the present invention is to provide a modified gene for mammals having expression level, in mammalian cells, tissues, organs or bodies, several times as high as that of phage-derived Cre recombinase. To attain the aforementioned object, the present invention provides a modified Cre recombinase gene for mammals consisting of codons frequently used in mammalian cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.